View in EDS

The potential role of daraxonrasib (RMC-6236) in relapsed neuroblastoma patients and the urgent need for preclinical investigations.

Saved in:
Bibliographic Details
Title: The potential role of daraxonrasib (RMC-6236) in relapsed neuroblastoma patients and the urgent need for preclinical investigations.
Authors: Gungormez EK; Basaksehir Cam and Sakura City Hospital, Department of Pediatric Surgery, Istanbul, Turkey., Sair O; Basaksehir Cam and Sakura City Hospital, Department of Pediatric Surgery, Istanbul, Turkey., Aydogdu H; Istanbul University, Istanbul Medical Faculty, Department of Pediatric Surgery, Istanbul, Turkey., Pederiva F; Pediatric Surgery Unit, Azienda Ospedaliera Universitaria Integrata (AOUI) Verona, Verona, Italy., Zorba Yildiz AP; Vocational School of Health Care Services, Istinye University, 34010 Istanbul, Turkey; Istinye University, Department of Stem Cell and Tissue Engineering & 3D Bioprinting, Istanbul, Turkey., Asir F; Department of Histology and Embryology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey., Azizoglu M; Basaksehir Cam and Sakura City Hospital, Department of Pediatric Surgery, Istanbul, Turkey; Istinye University, Department of Stem Cell and Tissue Engineering & 3D Bioprinting, Istanbul, Turkey. Electronic address: mdmazizoglu@gmail.com.
Source: Journal of pediatric surgery [J Pediatr Surg] 2026 Jun 29, pp. 163278. Date of Electronic Publication: 2026 Jun 29.
Publication Type: Letter
Journal Info: Publisher: Saunders Country of Publication: United States NLM ID: 0052631 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-5037 (Electronic) Linking ISSN: 00223468 NLM ISO Abbreviation: J Pediatr Surg Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1531-5037
DOI:10.1016/j.jpedsurg.2026.163278